Jci_page_head_homepage_01 Jci_page_head_homepage_02
Michael J. Lodes, Yingzi Cong, Charles O. Elson, Raodoh Mohamath, Carol J. Landers, Stephan R. Targan, Madeline Fort, Robert M. Hershberg
Published in Volume 113, Issue 9
J Clin Invest. 2004; 113(9):1296–1306 doi:10.1172/JCI20295
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 4

ELISA titration of mouse serum anti-flagellin against recombinant flagellins CBir1 and Fla-X with secondary antibodies specific for mouse IgG, IgG1, and IgG2a antibodies. Colitic C3H/HeJBir serum (pool of five) versus noncolitic C3H/HeJ serum (pool of two) was used in the upper panel and colitic mdr1a–/– serum (pool of five) versus noncolitic FVB serum (pool of five) was used in the lower panel.